Email updates

Keep up to date with the latest news and content from Critical Care and BioMed Central.

This article is part of the supplement: Sepsis 2012

Poster presentation

Monocytic and neutrophilic CD11b and CD64 in severe sepsis

J Jämsä1*, V Huotari2, ER Savolainen2, H Syrjälä2 and T Ala-Kokko2

  • * Corresponding author: J Jämsä

Author Affiliations

1 University of Oulu, Finland

2 Oulu University Hospital, Oulu, Finland

For all author emails, please log on.

Critical Care 2012, 16(Suppl 3):P41  doi:10.1186/cc11728


The electronic version of this article is the complete one and can be found online at: http://ccforum.com/content/16/S3/P41


Published:14 November 2012

© 2012 Jämsä et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Background

Leukocyte immunophenotyping could improve sepsis diagnostics [1,2]. Our hypothesis was that monocytic and neutrophilic CD11b and CD64 antigen fluorescence intensities differ between severe sepsis, non-inflammatory ICU patients and nonseptic inflammation (off-pump coronary artery bypass (OPCABG)).

Methods

Monocytic and neutrophilic CD11b and CD64 expressions were analyzed from 27 patients with severe sepsis, seven OPCABG patients and from eight ICU patients who did not fulfill any SIRS criteria. Blood samples were collected within 48 hours from the beginning of severe sepsis or in non-SIRS patients from ICU admission and two consecutive days (D0, D1, D2). From surgical patients, the first samples were taken on the day of surgery before the skin incision and two consecutive days (D0, D1, D2). In addition 10 healthy individuals served as controls. Samples were collected, processed and analyzed using flow cytometry as previously described [3].

Results

The maximum fluorescence intensities of monocytic and neutrophilic CD11b and CD64 were highest in septic patients compared with the other groups (P < 0.05) (Figure 1). In severe sepsis, fluorescence intensities decreased over time (P < 0.05). In OPCABG the fluorescence intensities of other antigens increased from D0 to D1 except neutrophilic CD11b (P < 0.05). The intensities of other antigens except neutrophilic CD64 were lower in the healthy than in all the other groups (P < 0.05). Neutrophilic CD64, as well as other antigens, were lower in healthy controls compared with severe sepsis at all time points (P < 0.05).

thumbnailFigure 1. Antigen fluorescence intensities in four groups in 3 days.

Conclusion

Based on this study, monocytic CD11b and neutrophilic CD64 could be helpful in distinguishing severe sepsis from nonseptic inflammation and healthy controls.

References

  1. Hoffmann J: Neutrophil CD64: A diagnostic marker for infection and sepsis.

    Clin Chem Lab Med 2009, 47:903-916. PubMed Abstract | Publisher Full Text OpenURL

  2. Nuutila J, Jalava-Karvinen P, Hohenthal U, Laitinen I, Kotilainen P, Rajamaki A, Nikoskelainen J, Lilius E: CRP/CD11b ratio: a novel parameter for detecting gram-positive sepsis.

    Hum Immunol 2009, 70:237-243. PubMed Abstract | Publisher Full Text OpenURL

  3. Jamsa J, Huotari V, Savolainen E-R, Syrjala H, Ala-Kokko T: Analysis of the temperature affects on leukocyte surface antigen expression.

    J Clin Lab Anal 2011, 25:118-125. PubMed Abstract | Publisher Full Text OpenURL